CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net (loss) income	$ (45,375)	$ 31,813	$ 4,693
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	13,807	14,009	13,794
Stock-based compensation expense	10,258	8,159	7,959
Inventory impairments and abandonments	6,949	2,445	15,282
Deferred and other income tax expense	93,935	678	15,903
Write-off of deposit on legacy land investment	0	2,700	0
Gain on sale of fixed assets	(351)	(294)	(957)
Change in allowance for doubtful accounts	48	(24)	(698)
Equity in income of unconsolidated entities and marketable securities	(127)	(401)	(143)
Cash distributions of income from unconsolidated entities	331	171	165
Non-cash loss on extinguishment of debt	3,289	3,677	4,978
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	11,875	16,927	(149)
Decrease in income tax receivable	88	204	127
(Increase) decrease in inventory	(95,809)	41,911	129,028
(Increase) in other assets	(1,300)	(168)	(471)
Increase (decrease) in trade accounts payable	17,492	(690)	(9,365)
Increase (decrease) in other liabilities	15,178	(25,208)	(17,121)
Net cash provided by operating activities	30,288	95,909	163,025
Cash flows from investing activities:
Capital expenditures	(17,020)	(12,440)	(12,219)
Proceeds from sale of fixed assets	370	297	2,624
Acquisition, net of cash acquired	(57,253)	0	0
Investments in unconsolidated entities	(421)	(3,261)	(4,241)
Return of capital from unconsolidated entities and marketable securities	176	1,621	1,142
Net cash used in investing activities	(74,148)	(13,783)	(12,694)
Cash flows from financing activities:
Repayment of debt	(497,915)	(265,483)	(828,221)
Proceeds from issuance of new debt	400,000	250,000	642,150
Repayment of borrowings from credit facility	(225,000)	(25,000)	(90,000)
Borrowings from credit facility	225,000	25,000	90,000
Debt issuance costs	(6,272)	(4,919)	(11,246)
Other changes	(3,314)	(391)	(222)
Net cash used in financing activities	(107,501)	(20,793)	(197,539)
(Decrease) increase in cash, cash equivalents, and restricted cash	(151,361)	61,333	(47,208)
Cash, cash equivalents, and restricted cash at beginning of period	304,609	243,276	290,484
Cash, cash equivalents, and restricted cash at end of period	$ 153,248	$ 304,609	$ 243,276